At Johnson & Johnson, we recognize that the people who use and rely on our products place their trust in us. Never taking this trust for granted, we implement significant measures to ensure reliability of our clinical research, scientific rigor of our medical publications, integrity in our professional relationships and independence of any medical education that receives our funding.
Health care professionals (HCPs) with real-world clinical experience in therapeutic areas that align with Johnson & Johnson areas of focus are uniquely qualified to provide education into new advancements related to our products and solutions. Our approach to working with these HCPs in both peer-to-peer education and product development is focused on improving the health of patients and driving optimal clinical outcomes through transparency and compliance.
As science sometimes advances quickly, peer-to-peer education allows providers to objectively discuss important medical information with colleagues related to the appropriate use of our products.
We also collaborate with leading physicians on the development of new surgical devices, medicines and other patient and consumer solutions. These activities lead to important medical advances that help to improve the lives of those we serve.
For all this partnership work, the Johnson & Johnson Family of Companies are governed by the following standards and other legal and voluntary requirements:
- Physician payment transparency reporting requirements, including the U.S. Open Payments program and the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code. For more information, see our statement on responsible interaction with health care professionals.
- U.S. and other laws and regulations and industry standards governing registration and reporting of clinical trial results.
- Standards published by the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents research-based pharmaceutical and biotechnology companies, and the Advanced Medical Technology Association (AdvaMed), which represents medical device manufacturers. These associations and similar industry organizations outside of the U.S. have established codes of ethics intended to protect medical decision-making from improper financial incentives.
Funding to Health Care Professionals
In addition to our disclosures, Johnson & Johnson operating companies work to prevent real or perceived conflicts of interest that may arise from relationships between companies and HCPs. Consistent with our ongoing commitment to ensure ethical and transparent interactions with medical professionals, we regularly review and update our practices that guide interactions with HCPs, institutions and other stakeholders in the health care system.
In addition to the disclosures noted above to government bodies, our pharmaceutical operating companies also report this funding on their websites.
Funding for Professional Education
We recognize our responsibility to support HCPs in staying educated and up-to-date on medical information and trends so they may provide the best patient care possible. Our pharmaceutical and medical devices operating companies disclose the nature and volume of grants they make for professional education on their websites.
Last updated: March 2018